UBS Downgrades CryoPort to Neutral, Lowers Price Target to $17
Portfolio Pulse from richadhand@benzinga.com
UBS analyst John Sourbeer has downgraded CryoPort (NASDAQ:CYRX) from Buy to Neutral and lowered the price target from $28 to $17.
July 18, 2023 | 1:34 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
CryoPort has been downgraded from Buy to Neutral by UBS, with a lowered price target from $28 to $17.
The downgrade from Buy to Neutral by UBS indicates a less optimistic outlook for CryoPort. The lowered price target from $28 to $17 suggests that the analyst believes the stock is overvalued at current levels. This could lead to a negative short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100